Use access key #2 to skip to page content.

IBDvalueinvestin (98.32)

HSP .90 eps qtr shows that its newly launched Chemo drug will have a major effect



October 27, 2009 – Comments (0) | RELATED TICKERS: HSP.DL

on its eps in future quarters.

Hospira said sales of specialty drugs -- or drugs that require special handling -- climbed 24 percent to $575.7 million. That was partly due to sales of a generic version of the chemotherapy drug oxaliplatin, which was launched during the quarter.

Oxaliplatin is a generic version of Sanofi-Aventis' drug Eloxatin.

0 Comments – Post Your Own

Featured Broker Partners